Intelligence · Clinical Pipeline
Prime Medicine Pipeline
All ClinicalTrials.gov programs at Prime Medicine — phase, modality, and trial IDs.
- Programs
- 17
Quick answer
Prime Medicine has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
PG-011 nasal spray 0.6%(twice daily)
Prime Medicine
Seasonal Allergic Rhinitis
1 trial -
PG-011Gel
Prime Medicine
Atopic Dermatitis
1 trial -
Recommended treatment schedule
Prime Medicine
COVID-19
1 trial -
Bemarituzumab
Prime Medicine
Gastric Cancer
1 trial -
FP-1039
Prime Medicine
Endometrial Cancers With FGFR2 Mutations
1 trial -
FPA008
Prime Medicine
Pigmented Villonodular Synovitis
1 trial -
PM359
Prime Medicine
Chronic Granulomatous Disease
1 trial -
Pumecitinib Nasal Spray 0.3%
Prime Medicine
Seasonal Allergic Rhinitis
1 trial -
Bemarituzumab
Prime Medicine
Gastrointestinal Cancer
1 trial -
Cabiralizumab
Prime Medicine
Advanced Solid Tumors
1 trial -
FP-1039
Prime Medicine
Advanced Cancer
1 trial -
FPA008
Prime Medicine
Healthy
1 trial -
FPA144
Prime Medicine
Advanced Solid Tumors
1 trial -
FPA150
Prime Medicine
Breast Cancer
1 trial -
FPT155
Prime Medicine
Advanced Solid Tumors
1 trial -
PG-033
Prime Medicine
Lichen Simplex Chronicus
1 trial -
Artificial intelligence in diagnosis
Prime Medicine
Artificial Intelligence (AI) in Diagnosis
1 trial
Frequently asked questions
How many pipeline programs does Prime Medicine have?
17 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs